Altimmune Inc (ALT)
4.255
+0.10
(+2.53%)
USD |
NASDAQ |
Jun 02, 16:00
4.255
0.00 (0.00%)
After-Hours: 17:47
Altimmune Price to Book Value: 1.250 for June 2, 2023
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 01, 2023 | 1.220 |
| May 31, 2023 | 1.187 |
| May 30, 2023 | 1.176 |
| May 26, 2023 | 1.202 |
| May 25, 2023 | 1.237 |
| May 24, 2023 | 1.261 |
| May 23, 2023 | 1.302 |
| May 22, 2023 | 1.317 |
| May 19, 2023 | 1.320 |
| May 18, 2023 | 1.308 |
| May 17, 2023 | 1.352 |
| May 16, 2023 | 1.366 |
| May 15, 2023 | 1.425 |
| May 12, 2023 | 1.496 |
| May 11, 2023 | 1.566 |
| May 10, 2023 | 1.464 |
| May 09, 2023 | 1.452 |
| May 08, 2023 | 1.446 |
| May 05, 2023 | 1.452 |
| May 04, 2023 | 1.452 |
| May 03, 2023 | 1.463 |
| May 02, 2023 | 1.393 |
| May 01, 2023 | 1.446 |
| April 28, 2023 | 1.484 |
| April 27, 2023 | 1.458 |
| Date | Value |
|---|---|
| April 26, 2023 | 1.534 |
| April 25, 2023 | 1.537 |
| April 24, 2023 | 1.622 |
| April 21, 2023 | 1.701 |
| April 20, 2023 | 1.684 |
| April 19, 2023 | 1.754 |
| April 18, 2023 | 1.675 |
| April 17, 2023 | 1.601 |
| April 14, 2023 | 1.405 |
| April 13, 2023 | 1.355 |
| April 12, 2023 | 1.208 |
| April 11, 2023 | 1.216 |
| April 10, 2023 | 1.187 |
| April 06, 2023 | 1.178 |
| April 05, 2023 | 1.137 |
| April 04, 2023 | 1.211 |
| April 03, 2023 | 1.299 |
| March 31, 2023 | 1.24 |
| March 30, 2023 | 1.122 |
| March 29, 2023 | 1.162 |
| March 28, 2023 | 1.176 |
| March 27, 2023 | 1.282 |
| March 24, 2023 | 1.149 |
| March 23, 2023 | 1.114 |
| March 22, 2023 | 1.117 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1709
Minimum
Sep 18 2018
13.39
Maximum
Jul 20 2020
1.948
Average
1.525
Median
Feb 28 2022
Price to Book Value Benchmarks
| Viking Therapeutics Inc | 16.58 |
| Rhythm Pharmaceuticals Inc | 4.610 |
| vTv Therapeutics Inc | -- |
| Geron Corp | 5.625 |
| Sarepta Therapeutics Inc | 16.35 |
Price to Book Value Related Metrics
| Price | 4.255 |
| Earnings Yield | -40.66% |
| Market Cap | 209.74M |